Also known as: Evercore
Evercore is an independent investment banking advisory firm focused on mergers and acquisitions, restructurings, financings, and related strategic transactions. Founded in 1995 and headquartered in New York City, it also provides institutional research and trading services. The company is publicly traded on the NYSE under EVR.
AbbVie shares declined 2% on March 13, 2026, amid reduced trading volume, while BMO Capital maintained its Outperform rating following Phase 1 obesity drug trial data for ABBV-295.
AbbVie reported Q4 earnings that beat consensus estimates with $16.62 billion in revenue, while facing competitive setbacks in psoriatic arthritis and Medicare pricing challenges for Botox.
AbbVie reported stronger-than-expected Q4 revenue of $16.62 billion and EPS of $2.71, beating consensus estimates. The company advanced a toxin-based therapy in Phase 2 trials and filed suit challenging Medicare drug-price negotiations for Botox.
